Tag:
Cancer
Latest Headlines
Latest Headlines
Compounds may combat cancers by reversing p53 mutation
Scientists at the Cancer Institute of New Jersey and the Institute for Advanced Study have identified a class of compounds--known as thiosemicarbazones--that appears in early testing to correct p53's mutation in mice. Treated with the compounds, tumors either stopped growing so quickly or shrank.
Cancer drug developers angling for center stage at ASCO
Later this week the cancer drug research crowd will examine a tsunami of abstracts filed ahead of the ASCO meeting in early June in the hopes of finding a few gems.
Amgen pushes agenda for biosimilars on the FDA
The Thousand Oaks, CA-base drugmaker is one of 30 organizations on the docket today for the FDA's informal stakeholder meeting to discuss regulation of biosimilars.
Stay calm, folks: Highly anxious mice developed more aggressive cancer
Cancer is bad enough, but anxiety could make the disease even worse as it progresses.
Novel drug blasts leukemia in zebra fish
Scientists believe they've identified a potential new treatment, dubbed Lenaldekar (LDK) which defeated T-cell acute lympoblastic leukemia in genetically modified zebrafish.
Bayer bolsters blockbuster case for regorafenib with new PhIII data
Bayer has racked up a fresh set of preliminary late-stage data that will bolster its plans to market regorafenib for a range of cancers.
Stanford CD47 breakthrough fights tumors in multiple cancers
Researchers from the Stanford University School of Medicine may have found a single treatment that, at least in mice, can beat back tumors from at least 7 cancers by welding antibodies to block the CD47 protein.
Radiation-infused nanoparticles wiped out brain tumors in rats
Human trials may launch within a few months for a new brain cancer treatment using nanoparticles infused with radiation that showed promise in rats.
Private equity player pumping $50M into cancer drug startup
The private equity group Celtic Therapeutics is committing $50 million to launch a startup biotech company with a mission to develop a portfolio of new antibody-drug-conjugates (ADCs) for cancer.
RNAi, smuggled in a virus, weakens tumors before final radiation blow
RNAi may be a great way to help weaken cancer cells before radiation therapy delivers the killing blow, Emory University scientists have found.
